Determination of olanzapine by spectrophotometry using permanganate

Brazilian Journal of Pharmaceutical Sciences

Volumn 45, Issue 3, 2009, Pages 539-550

  Rajendraprasad, Nagaraju ^a   Basavaiah, Kanakapura ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Olanzapine determination; Permanganate; Pharmaceuticals; Spectrophotometry

Indexed keywords

ACID; ALKALI; OLANZAPINE; OLEANZ; OLIMELT; PERMANGANATE POTASSIUM; UNCLASSIFIED DRUG;

ABSORPTION; ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; RELIABILITY; SENSITIVITY ANALYSIS; SPECTROPHOTOMETRY; TABLET; VALIDATION PROCESS;

EID: 76149087161     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502009000300020     Document Type: Article

References (45)

1. ABDELLATEF, H. E. Kinetic spectrophotometric determination of tramadol hydrochloride in pharmaceutical formulation. J. Pharm. Biomed. Anal., v.29, n.5, p.835-842, 2002.
2. AL-GHANMAN S.M.; BELAL, F. Spectrophotometric determination of diloxanide furoate in its dosage forms. Il Farmaco, v.56, n.9, p.677-681, 2001.
3. AL-TAMRAH, S. A. Spectrophotometric determination of nicotine. Anal. Chim. Acta., v.379, n.1-2, p.75-80,1999.
4. BAO, J.Q.; POTTS, B.D. Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B, v.752, n.1, p.61-67, 2001.
5. BASSET, J.; DENNEY, R.C.; JEFFREY, G.H.; MENDHAM, J. Vogel's textbook of quantitative chemical analysis. 5.ed. London: Longman Group Limited., 1978. p.368
6. BERNA, M.; ACKERMANN, B.; RUTERBORIES, K.; GLASS, S. Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B, v.767, n.1, p.163-168, 2002.
7. BOULTON, D.W.; MARKOWITZ, J.S.; DEVANE, C.L.; A high-performance liquid chromatography assay with ultraviolet detection for olanzapine in human plasma and urine. J. Chromatogr. B, v.759, n.2, p.319-323, 2001.
8. BRIGHT, H.A. Vogel text book of inorganic analysis including elementary instrumental analysis. 3.ed. London: Longman Group Limited, 1962. p.280.
9. CONCETTA, D.; GAETANA, M.; VINCENZA, S.; EDOARDO, S. Determination of olanzapine in human-plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection. Ther. Drug Monit., v.28, n.3, p.388-393, 2006.
10. DUSCI, L. J.; HACKETT, L.P.; FELLOWS, L.M.; ILETT, K.F. Determination of olanzapine in plasma by high-performance liquid chromatography using ultraviolet absorbance detection. J. Chromatogr., B, v.773, n.2, p.191-197, 2002.
11. FEDCHENKO, S.B. Determination of chloramphenicol in 0.25% solution. Farmatsiya (Moscow). v.33, n.1, p.68-69, 1984.
12. FIRDOUS, S.; AMAN, T.; NISA, A. Determination of olanzapine by UV spectrophotometry and non-aqueous titration. J. Chem. Soc. Pak, v.27, n.2, p.163-167, 2005.
13. HARALD, W.; SEBASTIAN, H.; SABINE, M.; WERNER, K.; GODEHARD, K.; GERD, D.; CHROSTOPH, H. Simultaneous determination olanzapine, clozapine and demethylated metabolites in serum by online columnswitching high-performance liquid chromatography. J. Chromatogr., B, v.759, n.1, p.63-71, 2001.
14. INCZEDY, J.; LENGYEL, T.; URE, A.M. IUPAC Compendium of analytical nomenclature : definitive rules. Boston: Blackwell Science Inc., 1998. No pagination.
15. INTERNATIONAL CONFERENCE ON HARMONIZATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Harmonised tripartite guideline. Validation of analytical procedures: Text and methodology Q2(R1). Complementary guideline on methodology. London: [s.n.], 1996. No pagination.
16. JASINSKA, A.; NALEWAJKO, E. Batch and flow-injection methods for the spectrophotometric determination of olanzapine. Anal. Chim. Acta, v.508, n.2, p.165-170, 2004.
17. KASPER, S.C.; MATTIUZ, E.L.; SWANSON, S.P.; CHIU, J.A.; JOHNSON, J.T.; GARNER C.O. Determination of olanzapine in human breast milk by high-performance liquid chromatography. J. Chromatogr. B, v.726, n.1-2, p.203-209, 1999.
18. KREBS, A.; STARCZEWSKA, B.; PUZANOWSHATARASIEWICZ, H.; SLEDZ, J. Spectrophotometric determination of olanzapine with N-bromosuccinimide and cerium(IV)sulphate. Anal. Sci., v.22, n.6, p.829-833, 2006.
19. KUCHARSKI, M.; SIKORSKA-TOMICKA, H. Potentiometric and amperometric determination of methyl thiouracil with potassium permanganate. Chem. Anal. (Warsaw), v.27, n.5-6. p.491-496, 1982.
20. MANN, F-G.; SOUNDERS, B. C. New impressions. 4.ed. Cambridge: Orient Longman, 1974. p.85.
21. MILLER, J.N.; MILLER, J.C. Statistics and chemometrics for analytical chemistry. 5.ed. New Jersey: Prentice-Hall, 2000. p.114.
22. MOHAMED, A.A. Kinetic and maximum-absorbance spectrophotometric methods for the determination of olanzapine. Monatsh. Chem., v.139, n.9, p.1005-1010, 2008.
23. MURUGESAN, A.; VENKAPPAYYA, D. New method for estimation of isoniazid. Curr. Sci., v.52, n.6, p.249-249, 1983.
24. OLESEN, O.V.; LINNET, K. Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidizability of the compound and the presence of other psychotropic drugs. J. Chromatogr. B, v.714, n.2, p.309-315, 1998.
25. OLESEN, O.V.; POULSEN, B.; LINNET, K. Fully automated online determination of olanzapine in serum for routine therapeutic drug monitoring. Ther. Drug Monit., v.23, n.1, p.51-55, 2001.
26. RAGGI, M.A.; CASAMENTI, G.; MANDRIOLI, R.; FANALI, S.; DE RONCHI, D.; VOLTERRA, V. Determination of the novel antipsychotic drug olanzapine in human plasma using HPLC with amperometric detection. Chromatographia, v.51, n.9-10, p.562-566, 2000.
27. RAGGI, M.A.; CASAMENTI, G.; MANDRIOLI, R.; IZZO, G.; KENNDLER, E.; Quantification of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. J. Pharm. Biomed. Anal., v.23, n.6, p.973-981, 2000.
28. RAGGI, M. A.; CASAMENTI, G.; MANDRIOLI, R.; VOLTERRA, V. A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-solid phase extraction procedure. J. Chromatogr. B, v.750, n.1, p.137-146, 2001.
29. RAGGI, M. A.; MANDRIOLI, R.; SABBIONI, C.; GHEDINI, N.; FANALI, S.; VOLTERRA, V. Determination of olanzapine and desmethylolanzapine in the plasma of schizophrenic patients by means of an improved HPLC method with amperometric detection. Chromatographia, v.54, n.3-4, p.203-207, 2001.
30. REDDY, M.N.; REDDY, V.P.N.; REDDY, P.J.C.; MURTHY, T.K.; SRINIVASA RAO, Y. Spectrophotometric determination of cefuroxime sodium in pharmaceutical dosage forms. Antiseptic., v.99, n.3, p.88-89, 2002.
31. REDDY, B.V.; SURESH REDDY, K.V.N.; SREERAMULU, J.; KANUMULA, G.V.; Simultaneous determination of olanzapine and fluoxetine by HPLC. Chromatographia, v.66, n.1-2, p.111-114, 2007.
32. SABBIONI, C.; SARACINO, M. A.; MANDRIOLI, R.; ALBERS, L.; ONCOMPAGNI, G.; RAGGI, M. A. Rapid analysis of olanzapine and desmethylolanzapine in human plasma using high-performance liquid chromatography with coulometric detection. Anal. Chim. Acta, v.516, n.1-2, p.111-117, 2004.
33. SARACINO, M.A.; GANDOLFI, O.; DALL'OLIO, R.O.; ALBERS, L.; KENNDLER, E.; RAGGI M,.A. Determination of olanzapine in rat brain using liquid chromatography with coulometric detection and a rapid solid-phase extraction procedure. J. Chromatogr. A, v. 1122, n.1-2, p.21-27, 2006.
34. SARACINO, M. A.; KOUKOPOULOS, A.; SANI, G.; AMORE, M.; RAGGI, M.A. Simultaneous high-performance liquid chromatographic determination of olanzapine and lamotrigine in plasma of bipolar patients. Ther. Drug Monitor., v.29, n.6, p.773-780, 2007.
35. SASTRY, C.S.P.; VIJAYA, R.T.; SATYANARAYANA, A. Spectrophotometric determination of pentazocine in pharmaceutical formulations. Indian. J. Pharm. Sci., v.60, n.1, p.55-58, 1998.
36. SHAH, C.R.; SHAH, N.J.; SUAGIA, B.N.; PATEL, N.M. Simultaneous Assay of Olanzapine and Fluoxetine in Tablets by Column High-Performance Liquid Chromatography and High-Performance Thin-Layer Chromatography. J. AOAC, v.90, n.6, p.1573-1578, 2007.
37. SHARMA, B.K. Instrumental methods of analysis. 18.ed. Meerut: Goel Publishing Home, 1994. p.114.
38. SHEN, W.W. The metabolism of atypical antipsychotic drugs: an update. Ann. Clin. Psych., v.11, n.3, p.145-158, 1999.
39. STEPNAYUK, S.N.; BALAGORAZUMNYA, N. V. Permanganometric determination of amidopyrine in dosage forms. Farmatsiya (Moscow)., v.38, n.1, p.67-69,1989.
40. SUGANTHI, A.; SHIVAKUMAR, H.B.; VIJAYKUMAR, S.C.; RAVIMATHI, P.; RAVI, T.K.; Visible spectrophotometric determination of valdecoxib in tablet dosage forms. Indian J. Pharm. Sci., v.68, n.3, p.373-374, 2006.
41. TAMMILEHTO, S.A. Oxidation of chlorprothinene with potassium permanganate. J. Pharm. Pharmacol., v.32, n.7, p.524-524, 1980.
42. THIEME, D.; SACHES, H. Imporoved screening capabilities in forensic toxicology by application of LC-MS-MS. Anal. Chim. Acta, v.492, n.1-2, p.171-186, 2003.
43. TITIER, K.; BOUCHET, S.; PEHOURCQ, F.; MOORE, N.; MOLIMARD, M. High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose. J. Chromatogr. B, v.788, n.1, p.179-185, 2003.
44. XUEJUN, X.; ZHONGHUA, T. Determination of olanzapine and its tablets by HPLC. Zhongguo Yiyao Gongye Zazhi, v.35, n.1, p.46-48, 2004.
45. ZAVIS, H.; LUDVIK, D.; MILAN, K.; LADISLAW, S.; FRANTISCK, V. Handbook of organic reagents in inorganic analysis. New York: John Wiley & Sons, 1976. p.364.